0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Diabetic Ketoacidosis Treatment Market to Reach USD 1.29 Billion by 2034 Amid Rising Prevalence of Diabetes and Innovations in Insulin DeliveryThe global diabetic ketoacidosis treatment market, valued at USD 864.63 million in 2024, is projected to reach USD 1,292.08 million by 2034, growing at a CAGR of 4.1% from 2025 to 2034. With the continued rise in diabetes-related complications, healthcare systems worldwide are increasing their focus on early detection and aggressive management of DKA—a...0 Comments 0 Shares 1K Views 0 Reviews
-
Dipeptidyl Peptidase IV (DPP-4) Inhibitors: Expanding Horizons in Type 2 Diabetes TreatmentDipeptidyl Peptidase IV (DPP-4) inhibitors, commonly known as gliptins, are a key category of oral medications for managing type 2 diabetes mellitus (T2DM). These drugs target the DPP-4 enzyme, which regulates glucose metabolism, and by inhibiting it, they enhance incretin hormone activity. This leads to improved insulin secretion and reduced glucagon release. Over the last twenty years, these...0 Comments 0 Shares 322 Views 0 Reviews
-
Global Diabetes Treatment Enters a Precision EraThe Global Diabetes Drugs Market reached US$ 78.11 billion in 2024 and is expected to reach US$ 141.73 billion by 2032, growing at a CAGR of 7.8 % during the forecast period 2025-2032, according to DataM Intelligence report. Unlock exclusive insights with our detailed sample report :...0 Comments 0 Shares 2K Views 0 Reviews
-
Transformative Breakthroughs Shaping the Future of Type 2 Diabetes CareIntroduction The global rise of Type 2 diabetes mellitus (T2DM) has intensified the demand for modern solutions that address insulin resistance and long-term metabolic disruption. As the condition’s impact expands, the healthcare landscape is increasingly focused on refining therapies, improving patient outcomes, and responding proactively to the growing prevalence of T2DM through more...0 Comments 0 Shares 92 Views 0 Reviews